Aktien Sensor

Sonova Holding AG’s stock rating has been upgraded to ‘Hold’ by Kepler Cheuvreux, despite the company’s stock price having decreased by 87% over the past year.

Cencora Inc’s stock price has increased by 21.1% over the past year, with investors seeing a return of over 20% on their initial investment.

Astellas Pharma’s stock price has risen, but the real story is Cresemba, an antifungal medication that has been a game-changer in the Asia Pacific region and China.

Lonza Group AG, a Swiss life sciences company, saw its stock price rise, contributing to a 0.39% gain in the SMI index on the SIX Swiss Exchange.

Haleon PLC’s stock price has surged after several leading investment banks upgraded their ratings and raised their price targets, boosting investor confidence in the company’s future prospects.

AstraZeneca’s shares have increased on the stock market following EU approval for its Calquence treatment, a milestone in the company’s commitment to innovative cancer treatments.

Philips reports progress in expanding access to quality healthcare through its philanthropic arm, while also announcing details for its 2024 dividend exchange ratio.

Otsuka’s stock price has declined to 6778 JPY, sparking concerns among investors, but its low valuation metrics may indicate an undervalued opportunity.

Viatris Inc, a pharmaceutical company, has seen its stock price recover in recent days, but faces ongoing challenges including a securities fraud lawsuit and a neutral rating from Goldman Sachs.

Teva Pharmaceutical Industries’ stock has seen significant growth, but safety concerns, including a recent recall of birth control pills, may pose risks for investors.